Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 05-2014 | 03-2014 | 02-2014 | 12-2013 | 11-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,230 | -11,110 | N/A | -8,710 | N/A |
| Depreciation Amortization | 1 | 1,690 | N/A | 1,280 | N/A |
| Other Working Capital | 1,090 | -1,070 | N/A | 2,430 | N/A |
| Other Operating Activity | -2,771 | 3,980 | 0 | 3,000 | 0 |
| Operating Cash Flow | $-450 | $-6,510 | $N/A | $-2,000 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -20 | N/A | 0 | N/A |
| Other Investing Activity | -7 | -18,580 | 0 | 2,650 | 0 |
| Investing Cash Flow | $-7 | $-18,600 | $N/A | $2,650 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 40 | 23,880 | 0 | 900 | 0 |
| Financing Cash Flow | $40 | $23,880 | $N/A | $900 | $N/A |
| Exchange Rate Effect | -5 | 730 | N/A | 10 | N/A |
| Beginning Cash Position | 610 | 1,140 | N/A | 1,150 | N/A |
| End Cash Position | 190 | 640 | N/A | 2,720 | N/A |
| Net Cash Flow | $-420 | $-490 | $N/A | $1,570 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -450 | -6,510 | N/A | -2,000 | N/A |
| Free Cash Flow | -450 | -6,510 | 0 | -2,000 | 0 |